Boehringer Ingelheim
Jacob Runyan serves as the Executive Director and Head of Scientific Affairs at Boehringer Ingelheim since April 2024, focusing on strategy, team management, and oversight of medical functions including Medical Information, Medical Accuracy Review, Medical Publications, Medical Education, and External Research in the U.S. Previously, Jacob held various roles at Boehringer Ingelheim from September 2002 to January 2024, including Director of Scientific Communications and Associate Director of Medical Publications. Jacob also spent ten years at Acorda Therapeutics, advancing to Sr. Director of Medical Affairs, and started a career in research at Vion Pharmaceuticals. Educationally, Jacob holds an MBA in Health Care Management and Compliance, an MSc in Molecular & Cellular Biology, and a BA in Biology from Quinnipiac University and Hiram College.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.